NURSES’ REPORTED TRAINING NEEDS FOR ADVANCED CELL THERAPIES : A SURVEY ON BEHALF OF THE NURSES GROUP OF THE EBMT
BACKGROUND Advanced Therapy Medicinal Products (ATMPs) for human use have advanced globally with the rapid adoption of Chimeric Antigen Receptor T-cell (CAR-T) therapies in haemato-oncology. CAR-T cell therapy and ATMPs have unique, significant acute and chronic toxicities, and appropriate patient care is crucial. Significant challenges, including the need for nurse education and training, accompa
